MacroGenics (NASDAQ:MGNX) Director Edward Hurwitz sold 308,513 shares of MacroGenics stock on the open market in a transaction dated Tuesday, February 18th. The stock was sold at an average price of $36.50, for a total value of $11,260,724.50. MacroGenics Inc (NASDAQ:MGNX) stock opened at $0.25 in last trading session, and closed at $35.65, trading in the range of $34.52 – $36.48. The stock showed a negative weekly performance of -4.11%.
Synthetic Biologics Inc (NYSEMKT:SYN), formerly Adeona Pharmaceuticals, Inc., is a biotechnology company focused on the development of synthetic deoxyribonucleic acid (DNA)-based therapeutics and disease-modifying medicines for serious illnesses. Its initial synthetic biologic product candidate is intended to treat pulmonary arterial hypertension (PAH) by delivering therapeutic DNA to the lungs of PAH patients and controlling long-term expression of such DNA via an oral daily pill. Synthetic Biologics Inc (NYSEMKT:SYN) stock advanced 8.61% and finished the last session at $2.65. The EPS of the stock remained -0.47. Company’s market capitalization is $153.70 billion.
Genetic Technologies Limited (ADR) (NASDAQ:GENE) average recommendation is buy average Target Price of $4.59. Genetic Technologies Limited (ADR) (NASDAQ:GENE) shares closed at $1.74 on last trade day, by losing -8.42%. Stock 52 week range is $1.30 – $3.35. Company’s market capitalization is $27.58 million.
OHR Pharmaceutical Inc (NASDAQ:OHRP) average recommendation is buy with average Target Price of $21.00. OHR Pharmaceutical Inc (NASDAQ:OHRP) stock opened at $ 13.84 in last trading session and closed at $14.70. The 52 week range of the stock is $ 4.11 – 16.89 and the day range was $ 13.60 – 15.20.
Leave a Reply